MRNA is expected to report earnings to fall 39.41% to -205 cents per share on July 30
Q2'26
Est.
$-2.06
Q1'26
Missed
by $1.38
Q4'25
Beat
by $0.51
Q3'25
Beat
by $1.54
Q2'25
Beat
by $0.85
The last earnings report on May 01 showed earnings per share of -340 cents, missing the estimate of -201 cents. With 12.45M shares outstanding, the current market capitalization sits at 24.52B.